ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 27, 2016

Primary Completion Date

January 4, 2021

Study Completion Date

December 31, 2021

Conditions
Advanced Non-small Cell Lung Cancer
Interventions
DRUG

ONO-4538

Trial Locations (8)

Unknown

Taichung Clinical Site 1, Taichung

Taichung Clinical Site 2, Taichung

Tainan Clinical Site 1, Tainan City

Tainan Clinical Site 2, Tainan City

Tainan Clinical Site 3, Tainan City

Taipei Clinical Site 1, Taipei

Taipei Clinical Site 2, Taipei

Taipei Clinical Site 3, Taipei

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY